Harbor–UCLA Medical Center, is a 570-bed public teaching hospital located at 1000 West Carson Street in West Carson, an unincorporated area within Los Angeles County, California.

There are 570 beds in Harbor-UCLA Medical Center.

During the past decade, Harbor-UCLA Medical Center conducted 94 clinical trials. In the 10-year time frame, 94 clinical trials started and 82 clinical trials were completed, i.e. on average, 87.2% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 47 clinical trials were completed. i.e. 134.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Harbor-UCLA Medical Center" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 101 trials, followed by "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center" with 16 trials sponsored, "Children's Oncology Group" with 10 trials sponsored, "United Therapeutics" with 10 trials sponsored and "Actelion" with 10 trials sponsored. Other sponsors include 173 different institutions and companies that sponsored additional 106 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harbor-UCLA Medical Center" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 14 trials as a collaborator, "University of California, Los Angeles" with 13 trials as a collaborator, "Bristol-Myers Squibb" with 12 trials as a collaborator, "Glaxo Wellcome" with 12 trials as a collaborator and "National Cancer Institute (NCI)" with 10 trials as a collaborator. Other collaborators include 181 different institutions and companies that were collaborators in the rest 126 trials.

According to Clinical.Site data, the most researched conditions in "Harbor-UCLA Medical Center" are "HIV Infections" (131 trials), "Pulmonary Arterial Hypertension" (23 trials), "Pulmonary Hypertension" (16 trials), "Pregnancy" (8 trials) and "Achondroplasia" (6 trials). Many other conditions were trialed in "Harbor-UCLA Medical Center" in a lesser frequency.

Most popular intervention types in "Harbor-UCLA Medical Center" are "Drug" (250 trials), "Device" (30 trials), "Other" (28 trials), "Biological" (19 trials) and "Procedure" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "Zidovudine" (38 trials), "Didanosine" (24 trials), "Lamivudine" (23 trials) and "Stavudine" (22 trials). Other intervention names were less common.

The vast majority of trials in "Harbor-UCLA Medical Center" are 301 trials for "All" genders, 12 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Harbor-UCLA Medical Center". undefined are not yet recruiting, 18 are recruiting, 19 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 243 completed trials in Harbor-UCLA Medical Center, 1 suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Harbor-UCLA Medical Center, 21 "Phase 1" clinical trials were conducted, 100 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 28 trials, and there were also 57 trials that are defined as “Not Applicable".

Harbor-UCLA Medical Center has several departments that took part in Clinical trials: "Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases" - 20 trials, "Harbor UCLA, Research & Education Institute" - 4 trials, "Harbor UCLA Pediatrics" - 2 trials, "Liu Center for Pulmonary Hypertension - LA Biomedical Research Institute at Harbor-UCLA" - 2 trials